Skip to main content

Conservative/Palliative Treatment and End-of-Life Care in Chronic Kidney Disease

  • Chapter
  • First Online:
Management of Chronic Kidney Disease
  • 380 Accesses

Abstract

There is an urgent unmet need for kidney supportive care services for patients with chronic kidney disease (CKD). Many have a high symptom burden that impairs their quality of life, multiple comorbid conditions, a shortened life expectancy, and significant cognitive and functional impairments. Kidney supportive care refers to primary palliative care provided directly by the kidney care team and includes the skills that ideally all providers should have: management of uncomplicated pain and symptoms including anxiety and depression, and essential discussions about prognosis, goals of treatment, code status, quality of life, and suffering. Palliative care usually indicates care provided by a subspecialty-level team that partners with the kidney clinicians to address more complicated symptoms and challenging communication or decisions. Because older patients with chronic kidney disease often have multiple comorbidities and a poor prognosis even with dialysis treatment, active medical management without dialysis (also known as conservative kidney management) is increasingly seen as an acceptable alternative to dialysis for these patients. This therapeutic option should be discussed along with dialysis options with all patients being educated about kidney replacement therapies. All CKD patients can potentially benefit from kidney supportive care; it is appropriate not only at the end of life but also throughout the course of CKD. Advance care planning can identify patient and family goals and thereby direct appropriate treatments. The illness trajectory of CKD typically offers multiple opportunities for nephrologists to initiate advance care planning discussions with patients and families. Advance directives like naming a health-care surrogate for decision-making and medical orders like do-not-resuscitate and Portable Orders for Life-Sustaining Treatment (POLST) where available should be completed by all CKD patients who desire treatment limitations at the end of life. Some discussion of prognosis is required in order for patients and families to complete advance directives and medical orders. It is the nephrologist’s role to initiate these conversations. End-of-life care is best delivered by an interdisciplinary team of providers focusing on the physical, psychological, and spiritual aspects of suffering and providing bereavement care to loved ones. Hospice is an example of such care and may benefit CKD patients choosing active medical management without dialysis as well as those who withdraw from dialysis.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 169.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 219.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Davison SN, Levin A, Moss AH, Jha V, Brown EA, Brennan F, Murtagh FE, Naicker S, Germain MJ, O’Donoghue DJ, Morton RL, Obrador GT, Kidney Disease: Improving Global Outcomes. Executive summary of the KDIGO controversies conference on supportive care in chronic kidney disease: developing a roadmap to improving quality care. Kidney Int. 2015;88(3):447–59.

    Article  PubMed  Google Scholar 

  2. Chandna SM, Da Silva-Gane M, Marshall C, Warwicker P. Survival of elderly patients with stage 5 CKD: comparison between conservative management and renal replacement therapy. Nephrol Dial Transplant. 2011;26:1608–14.

    Article  PubMed  Google Scholar 

  3. Renal physicians association clinical practice guideline for shared decision making in the appropriate initiation and withdrawal from dialysis. 2nd ed. Rockville: Renal Physicians Association; 2010.

    Google Scholar 

  4. Couchoud C, Labeeuw M, Moranne O, Allot V, Esnault V, Frimat L, et al. A clinical score to predict 6-month prognosis in elderly patients starting dialysis for end-stage renal disease. Nephrol Dial Transplant. 2009;24:1553–61.

    Article  PubMed  Google Scholar 

  5. Conway B, Webster A, Ramsay G, Morgan N, Neary J, Whitworth C, et al. Predicting mortality and uptake of renal replacement therapy in patients with stage 4 chronic kidney disease. Nephrol Dial Transplant. 2009;24:1930–7.

    Article  CAS  PubMed  Google Scholar 

  6. Cohen LM, Ruthazer R, Moss AH, Germain MJ. Predicting six-month mortality for patients who are on maintenance hemodialysis. Clin J Am Soc Nephrol. 2010;5:72–9.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Brown M, Chou A, Li C, Farshid S, Hoffman A. Survival, symptoms and hospitalisation of older patients with advanced CKD managed without dialysis. Nephrol Dial Transplant. 2023;38(2):405–13. https://doi.org/10.1093/ndt/gfac154.

    Article  CAS  PubMed  Google Scholar 

  8. Carson RC, Juszczak M, Davenport A, Burns A. Is maximum conservative management an equivalent treatment options to dialysis for elderly patients with significant comorbid disease? Clin J Am Soc Nephrol. 2009;4:1611–9.

    Article  PubMed  PubMed Central  Google Scholar 

  9. Brunori G, Viola BF, Parrinello G, DeBiase V, Como G, Franco V, et al. Efficacy and safety of a very low protein diet when postponing dialysis in the elderly: a prospective, randomized, multicenter, controlled study. Am J Kidney Dis. 2007;49:569–80.

    Article  CAS  PubMed  Google Scholar 

  10. Murtagh FE, Marsh JE, Donohoe P, Ekbal NJ, Sheerin NS, Harris FE. Dialysis or not? A comparative survival study of patients over 75 years with chronic kidney disease stage 5. Nephrol Dial Transplant. 2007;22:1955–62.

    Article  PubMed  Google Scholar 

  11. Joly D, Anglicheau D, Alberti C, Nguyen A-T, Touam M, Grunfeld J-P, et al. Octogenarians reaching end-stage renal disease: cohort study of decision-making and clinical outcomes. J Am Soc Nephrol. 2003;14:1012–21.

    Article  PubMed  Google Scholar 

  12. DaSilva-Gane M, Wellsted D, Greenshields H, Norton S, Chadna SM, Farrington K. Quality of life and survival in patients with advanced kidney failure managed conservatively or by dialysis. Clin J Am Soc Nephrol. 2012;7:2002–9.

    Article  Google Scholar 

  13. Murtagh FEM, Sheerin NS, Addington-Hall J, Higginson IJ. Trajectories of illness in stage 5 chronic kidney disease: a longitudinal study of patient symptoms and concerns in the last year of life. Clin J Am Soc Nephrol. 2011;7:1580–90.

    Article  Google Scholar 

  14. Holley JL. Advance care planning in CKD/ESRD: an evolving process. Clin J Am Soc Nephrol. 2012;7:1033–8.

    Article  PubMed  Google Scholar 

  15. Singer PA, Martin DK, Kelner M. Quality end-of-life care: patients’ perspectives. JAMA. 1999;281:163–8.

    Article  CAS  PubMed  Google Scholar 

  16. Steinhauser K, Chastakis NA, Clipp ED, McNeilly M, McIntyre L, Tulsky JA. Factors considered important at the end of life by patients, family, physicians, and other care providers. JAMA. 2000;248:2476–82.

    Article  Google Scholar 

  17. Abdel-Kader K, Unruh ML, Weisbord SD. Symptom burden, depression, and quality of life in chronic and end-stage kidney disease. Clin J Am Soc Nephrol. 2009;4(6):1057–64.

    Article  PubMed  PubMed Central  Google Scholar 

  18. Davison SN. The prevalence and management of chronic pain in ESRD. J Palliant Med. 2007;10:1277–87.

    Article  Google Scholar 

  19. Coalition for supportive care of kidney patients. Active medical management without dialysis pathway. go.gwu.edu/ammwd. Accessed 29 Nov 2022.

    Google Scholar 

  20. Li K, Brown M. Active medical management without dialysis for patients with advanced chronic kidney disease. In: Moss AH, Lupu DE, Armistead NC, Diamond LH, editors. Palliative care in nephrology. New York: Oxford University Press; 2020. p. 136–47.

    Google Scholar 

  21. Douglas C, Murtagh FEM, Chambers EJ, Howse M, Ellershaw J. Symptom management for the adult patient dying with advanced chronic kidney disease: a review of the literature and development of evidence-based guidelines by a United Kingdom Expert Consensus Group. Palliant Med. 2009;23:103–10.

    Article  CAS  Google Scholar 

  22. Davison SN. The ethics of end-of-life care for patients with ESRD. Clin J Am Soc Nephrol. 2012;7:2049–57.

    Article  PubMed  Google Scholar 

  23. Fishbane S, Jamal A, Munera C, Wen W, Menzaghi F, KALM-1 Trial Investigators. A Phase 3 trial of difelikefalin in hemodialysis patients with pruritus. N Engl J Med. 2020;382(3):222–32.

    Article  CAS  PubMed  Google Scholar 

  24. Davison SN, Simpson C. Hope and advance care planning in patients with end stage renal disease: qualitative interview study. BMJ. 2006;333(7574):886.

    Article  PubMed  PubMed Central  Google Scholar 

  25. Murtagh FE, Addington-Hall J, Edmonds P, Donohoe P, Carey I, Jenkins K, et al. Symptoms in the month before death for stage 5 chronic kidney disease patients managed without dialysis. J Pain Symptom Manag. 2010;40:342–52.

    Article  Google Scholar 

  26. Cohen LM, Germain MJ, Woods AL, Mirot A, Burleson JA. The family perspective of ESRD deaths. Am J Kidney Dis. 2005;45:154–61.

    Article  PubMed  Google Scholar 

  27. Levin A, Hemmelgarn B, Culleton B, Tobe S, McFarlane P, Ruzicka M, et al. Guidelines for the management of chronic kidney disease. CMAJ. 2008;179:1154–62.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Alvin H. Moss .

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2023 The Author(s), under exclusive license to Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Moss, A.H. (2023). Conservative/Palliative Treatment and End-of-Life Care in Chronic Kidney Disease. In: Arıcı, M. (eds) Management of Chronic Kidney Disease. Springer, Cham. https://doi.org/10.1007/978-3-031-42045-0_36

Download citation

  • DOI: https://doi.org/10.1007/978-3-031-42045-0_36

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-031-42044-3

  • Online ISBN: 978-3-031-42045-0

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics